About the job
ByHeart is dedicated to improving infant nutrition by developing formulas that closely match the composition of breast milk. The company’s work is grounded in nutritional science and includes a decade of research and the largest clinical trial for a new formula brand in the past 25 years.
With its own manufacturing facilities, ByHeart has created a patented protein blend that features lactoferrin and alpha-lactalbumin, two proteins found abundantly in breast milk. This approach supports easier digestion for infants and mirrors the natural balance found in breast milk.
In addition to product development, ByHeart supports families through the OpenHearted program, which has delivered over one million feeds to those experiencing hardship. The company responded to the 2023 formula shortage by expanding its U. S. manufacturing with two new sites, strengthening the supply of high-quality, rigorously tested formula.
Following a production incident in November 2025, ByHeart partnered with the FDA and industry experts to audit and enhance its processes. These improvements have shaped industry testing standards and are designed to prevent future issues.
Safety and transparency guide every aspect of ByHeart’s work, with family well-being always at the forefront.
